Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Medicine|April 2, 2022
Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responsesEimear Mylod, Ellen McKenna, Maria Davern, et al.
Oncotarget|December 22, 2016
MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotypeNiamh Lynam-Lennon, Susan Heavey, Gary Sommerville, et al.
International Journal of Colorectal Disease|July 14, 2009
Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancerDermot T McDowell, Fraser M Smith, John V Reynolds, et al.
Cancer Research Communications|March 27, 2023
Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysisLaura E Kane, Gregory S Mellotte, Eimear Mylod, et al.
Scientific Reports|March 1, 2022
PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinomaMaria Davern, Rebecca M O' Brien, Jason McGrath, et al.
Translational Oncology|March 25, 2021
Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cellsMaria Davern, Noel E Donlon, Andrew Sheppard, et al.
Cancers|December 17, 2024
Targeting Radiation Resistance in Oesophageal Adenocarcinoma with Pyrazinib-Functionalised Gold NanoparticlesSimone Marcone, Jolanda Spadavecchia, Memona Khan, et al.
Scientific Reports|January 3, 2025
Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer developmentLaura E Kane, Gregory S Mellotte, Eimear Mylod, et al.
Translational Oncology|April 2, 2022
Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinomaMaria Davern, Noel E Donlon, Fiona O' Connell, et al.
Translational Oncology|March 4, 2022
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumoursMaria Davern, Marie-Claire Fitzgerald, Croí E Buckley, et al.
Pageof 5